HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuyoshi Nishiyama Selected Research

Tsuyoshi Nishiyama Research Topics

Disease

3Lymphatic Metastasis
04/2022 - 12/2020
3Neoplasm Metastasis (Metastasis)
11/2021 - 12/2020
2Neoplasms (Cancer)
04/2022 - 12/2020
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2020 - 12/2020
1COVID-19
04/2022
1Hyperammonemia
12/2020
1Adenocarcinoma
12/2020
1Fatigue
12/2020
1Hepatocellular Carcinoma (Hepatoma)
12/2020
1Sigmoid Neoplasms
12/2020
1Hemorrhage
01/2020
1False Aneurysm (Pseudoaneurysm)
01/2020
1Klatskin Tumor
01/2020
1Postoperative Hemorrhage
01/2020

Drug/Important Bio-Agent (IBA)

2GemcitabineFDA Link
04/2022 - 12/2020
1Cisplatin (Platino)FDA LinkGeneric
04/2022
1Sorafenib (BAY 43-9006)FDA Link
04/2022
1Carboplatin (JM8)FDA LinkGeneric
11/2021
1Etoposide (VP 16)FDA LinkGeneric
11/2021
1130-nm albumin-bound paclitaxelIBA
12/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2020
1Branched-Chain Amino AcidsIBA
12/2020
1Fluorouracil (Carac)FDA LinkGeneric
12/2020
1SolutionsIBA
12/2020
1folfirinoxIBA
12/2020

Therapy/Procedure

4Drug Therapy (Chemotherapy)
04/2022 - 12/2020
4Therapeutics
12/2020 - 01/2020
1Hepatectomy
04/2022
1Lymph Node Excision (Lymph Node Dissection)
04/2022
1Adjuvant Chemotherapy
11/2021
1Stents
01/2020